1. Home
  2. DAR vs RGEN Comparison

DAR vs RGEN Comparison

Compare DAR & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Darling Ingredients Inc.

DAR

Darling Ingredients Inc.

HOLD

Current Price

$65.23

Market Cap

9.7B

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$177.30

Market Cap

10.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAR
RGEN
Founded
1882
1981
Country
United States
United States
Employees
N/A
2000
Industry
Packaged Foods
Medical/Dental Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
10.0B
IPO Year
2002
1995

Fundamental Metrics

Financial Performance
Metric
DAR
RGEN
Price
$65.23
$177.30
Analyst Decision
Strong Buy
Buy
Analyst Count
11
12
Target Price
$65.82
$167.67
AVG Volume (30 Days)
2.5M
914.0K
Earning Date
04-30-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
286.96
EPS
3.24
0.24
Revenue
$6,135,877,000.00
$141,236,000.00
Revenue This Year
$7.78
$14.30
Revenue Next Year
$3.37
$14.52
P/E Ratio
$20.52
$742.46
Revenue Growth
7.36
35.10
52 Week Low
$29.15
$100.99
52 Week High
$69.98
$188.73

Technical Indicators

Market Signals
Indicator
DAR
RGEN
Relative Strength Index (RSI) 50.49 61.30
Support Level $57.88 $158.15
Resistance Level $69.31 $188.73
Average True Range (ATR) 2.38 6.73
MACD -0.21 -0.25
Stochastic Oscillator 51.71 79.98

Price Performance

Historical Comparison
DAR
RGEN

About DAR Darling Ingredients Inc.

Darling Ingredients Inc develops and produces sustainable natural ingredients from edible and inedible bio-nutrients for the pharmaceutical, food, pet food, animal feed, industrial, fuel, bioenergy, and fertilizer industries. The Company collects and processes animal by-products and recycled oils into ingredients. It operates through three reportable segments: Feed Ingredients, which generates maximum revenue and includes the collection and processing of animal by-products, used cooking oil, bakery residuals, pet food ingredients, hides, and fertilizers; Food Ingredients, which includes collagen, natural casings, and food-grade fats; and Fuel Ingredients, which includes renewable fuels, biogas, and energy products. The Company derives the majority of its revenue from North America.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: